Where is Mallinckrodt Pharmaceuticals located?

Mallinckrodt Pharmaceuticals is headquartered in Staines, United Kingdom and has 4 office locations across 3 countries.

Is Mallinckrodt generic?

A. Mallinckrodt offers branded and generic products. We do offer patient assistance on select branded products for those patients meeting the program criteria. We do not offer patient assistance for our generic products.

Is Mallinckrodt still in business?

Mallinckrodt, represented by Latham & Watkins, filed for bankruptcy in October with $5.3 billion in funded debt to resolve widespread litigation brought by states, local governments and private individuals accusing it of deceptively marketing opioids.

Is Mallinckrodt a Fortune 500 company?

Fortune 500 2000 Huntington Bancshares, Inc.

Where is Mallinckrodt Pharmaceuticals registered in Ireland?

© 2018 Mallinckrodt. Mallinckrodt Pharmaceuticals is a registered business name of Mallinckrodt plc, which is registered in Ireland as a public limited company with registration number 522227 and has its registered office at College Business & Technology Park, Cruiserath, Blanchardstown, Dublin 15, Ireland.

How to report concerns about Mallinckrodt business practices?

For the ability to report concerns about Mallinckrodt’s business practices, please feel free to contact our Integrity Hotline at (888) 696-9864. For areas outside of the United States and Canada, please click here for country access codes and dialing information using ATT Direct Access Service.

How are cookies used at mallinckrodt.com?

Mallinckrodt uses cookies to improve and analyze site functionality. Some aspects of the site may not function properly without cookies enabled. To learn more about how we use cookies and how you can change your cookies settings, please read our Privacy Policy.

When did Mallinckrodt Chemical Works become a company?

Mallinckrodt Chemical Works was incorporated 15 years later, in 1882. By 1898, the company had established itself as a pharmaceuticals supplier and in 1913 became the first to introduce barium sulfate as a contrast medium for x-rays.